CEO Emma Walmsley said the company has been anticipating tariffs on the industry and is “confident” the company can navigate through it, Ashleigh Furlong and Ruth David of Bloomberg reports. The U.S.

By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated ...

PHILADELPHIA, February 17, 2025--PENMENVY, GSK’s 5-in-1 meningococcal vaccine, approved by US FDA to help protect against MenABCWY ViiV Healthcare, the global specialist HIV company majority ...

The company, based in Dundee, Scotland, says it has already produced drug candidates for other clients in one quarter of the time normally needed. Exscientia and GSK aim to discover novel and ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK defended the wording of the prescribing information and its processes. The company denied it had breached the code, arguing that the line was taken verbatim from part of the summary of product ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Blenrep’s potential global reentry also gave GSK confidence to boost its 2031 sales target to more than 40 billion pounds despite uncertainties around the company’s flagship vaccines business.